$87.37
-1.34-1.51%
At close: -
$87.44
0.070.08%
After Hours: 4:59 PM EDT
Novo Nordisk reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novo Nordisk using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $0.90 | $0.88 | 2.27 % |
Jun 2024 | 2024-08-07 | $0.65 | $0.69 | -5.80 % |
Mar 2024 | 2024-05-02 | $0.83 | $0.74 | 12.2 % |
Dec 2023 | 2024-01-31 | $0.71 | $0.65 | 9.08 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $10.50B | $10.49B | 0.13 % |
Jun 2024 | 2024-08-07 | $9.82B | $9.97B | -1.49 % |
Mar 2024 | 2024-05-02 | $9.52B | $9.07B | 4.93 % |
Dec 2023 | 2024-01-31 | $9.50B | $8.82B | 7.75 % |
Novo Nordisk (NVO) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $0.90, which beat the estimate of $0.88.
The Actual Revenue was $10.5B, which beat the estimate of $10.5B.
Browse earnings estimates, EPS, and revenue on all stocks.